Cleared Traditional

K250934 - Respiree Cardio- Respiratory Monitor System (FDA 510(k) Clearance)

Aug 2025
Decision
130d
Days
Class 2
Risk

K250934 is an FDA 510(k) clearance for the Respiree Cardio- Respiratory Monitor System. This device is classified as a Monitor, Breathing Frequency (Class II - Special Controls, product code BZQ).

Submitted by Respiree Pte, Ltd. (Singapore Central, SG). The FDA issued a Cleared decision on August 5, 2025, 130 days after receiving the submission on March 28, 2025.

This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 868.2375.

Submission Details

510(k) Number K250934 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 28, 2025
Decision Date August 05, 2025
Days to Decision 130 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF

Device Classification

Product Code BZQ - Monitor, Breathing Frequency
Device Class Class II - Special Controls
CFR Regulation 21 CFR 868.2375